Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daiwa Securities Group is a leading Japanese financial services holding company and one of the country's largest independent investment banks. Headquartered in Tokyo, the group operates across several core business segments, including wealth management, asset management, and investment banking. While the group is not a biotechnology or pharmaceutical company itself, it plays a significant role in the life sciences ecosystem through its investment arms, such as Daiwa Corporate Investment, which provides venture capital to healthcare and medical technology startups. The company is a major underwriter for healthcare IPOs in the Japanese market and manages various investment funds focused on innovation. Daiwa Securities Group is publicly traded on the Tokyo Stock Exchange and maintains a global presence with offices in major financial hubs across Asia, Europe, and North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daiwa Securities Group.